AJP - Lung Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 287: L569-L576, 2004. First published May 21, 2004; doi:10.1152/ajplung.00117.2004
1040-0605/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/L569    most recent
00117.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matecki, S.
Right arrow Articles by Petrof, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matecki, S.
Right arrow Articles by Petrof, B. J.

Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes

Stefan Matecki,1 Roy W. R. Dudley,1 Maziar Divangahi,1 Renald Gilbert,2,3 Josephine Nalbantoglu,2 George Karpati,2 and Basil J. Petrof1,2

1Meakins-Christie Laboratories and Respiratory Division, McGill University Health Center, McGill University, Montréal H3A 1A1; 2Neuromuscular Research Group, Montréal Neurological Institute, McGill University, Montréal H3A 2B4; and 3Biotechnology Research Institute, National Research Council of Canada, Montréal, Québec, Canada H4P 2R2

Submitted 29 March 2004 ; accepted in final form 13 May 2004

Duchenne muscular dystrophy is caused by defects in the dystrophin gene, and the mdx mouse is the most frequently employed genetic model of this disease. It is well known that different muscle groups do not respond in the same way to dystrophin deficiency. In particular, the mdx mouse diaphragm exhibits severe morphological and functional changes not found in other mdx muscles. Use of early generation adenoviral vectors to deliver genes to the diaphragm in immunocompetent mdx mice has been associated with substantial functional toxicity and a rapid loss of transgene expression. Here we determined the response to dystrophin gene replacement in the mdx diaphragm using a "gutted" adenoviral vector that contains the coding sequence of two full-length dystrophin genes and is deleted of most viral DNA sequences. At 1 wk postdelivery of the vector, 23.6 ± 4% of total fibers in the injected diaphragm bundle expressed dystrophin at the sarcolemma, which remained stable over the study duration of 30 days without the need for continuous immunosuppression. Treated diaphragms showed a significantly improved resistance to the abnormal force deficits induced by high-stress muscle contractions, the latter being a functional hallmark of dystrophin-deficient muscle. This functional amelioration was achieved despite the presence of mildly increased inflammation (CD4+ and CD8+ lymphocytes) within the vector-treated diaphragms. To our knowledge, this is the first demonstration that a viral vector can achieve reversal of functional abnormalities in the dystrophic diaphragm via therapeutic dystrophin gene transfer without the need for sustained immunosuppressive therapy.

Duchenne muscular dystrophy; gene therapy; dystrophin deficiency; viral vectors; mdx mouse


Address for reprint requests and other correspondence: B. J. Petrof, Respiratory Division, Rm. L411, Royal Victoria Hospital, 687 Pine Ave. W., Montréal, Québec, Canada H3A 1A1 (E-mail: basil.petrof{at}mcgill.ca)




This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. Adriaansen, M. J. B. M. Vervoordeldonk, and P. P. Tak
Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes
Rheumatology, June 1, 2006; 45(6): 656 - 668.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. R. A. Aoki, H. Liu, G. P. Downey, J. Mitchell, and R. L. Horner
Cyclic Nucleotides Modulate Genioglossus and Hypoglossal Responses to Excitatory Inputs in Rats
Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 555 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
A. Demoule, M. Divangahi, G. Danialou, D. Gvozdic, G. Larkin, W. Bao, and B. J. Petrof
Expression and Regulation of CC Class Chemokines in the Dystrophic (mdx) Diaphragm
Am. J. Respir. Cell Mol. Biol., August 1, 2005; 33(2): 178 - 185.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.